Teva enters pact with Klinge Biopharma, Formycon to commercialize FYB203
Teva (TEVA) announced that it has entered into a strategic collaboration with Klinge Biopharma and Formycon for the semi-exclusive ...
Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel
Klinge Biopharma GmbH (Klinge) holds the exclusive global commercialization rights for FYB203, Formycon's biosimilar candidate to ...
Indiatimes1h
Mankind Pharma Share Price
Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,13,041.27 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...
Indiatimes6m
Piramal Pharma Share Price
Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...